Home » Topics » BioWorld Science

BioWorld Science
RSS

WHO studies role of progesterone in HIV transmission

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

HIV vaccine research at NIAID

Aug. 16, 1996

HIV integrase inhibitor effective, non-toxic in vitro

Aug. 16, 1996

Higher doses of GEM-91 administered in phase I/II trial

Aug. 16, 1996

Preclinical development of GEM-92 underway at Hybridon

Aug. 16, 1996

Bayer discloses HIV protease inhibitors

Aug. 16, 1996

HHV-8 implicated in KS development

Aug. 16, 1996

Lidak initiates further trials of Lidakol in oral herpes

Aug. 16, 1996

Hybridon prepares for GEM-132 clinical testing

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...